Megan Bielawski, M.D.
Rheumatology Physician in Akron, Ohio. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,181 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Megan Bielawski, M.D. reported a CMS MIPS final score of 93/100 - above the 83.1 national average - and filed 2,494 Medicare Part D claims in 2023.
- 93/100
- MIPS score · +10 vs avg
- 2K
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Megan Bielawski, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
93 Top 32% higher than 68% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Megan Bielawski, M.D. sits
This provider among rheumatology physician peers
Across the 2,181 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Megan Bielawski, M.D. writes more Part D claims than 62% of them and scores higher on MIPS quality than 71% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Megan Bielawski, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Megan Bielawski, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Megan Bielawski, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Ohio
How Rheumatology Physician compares to other specialties among Ohio providers
Largest specialties in Ohio (% of in-state providers)
Rheumatology Physician ranks #112 among Ohio's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Ohio provider total, by primary NUCC taxonomy. The highlighted bar is Rheumatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Megan Bielawski, M.D.'s 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 93/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Rheumatology Physician) - 93/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Rheumatology Physician US NPIs
93/100 MIPS final score - 9.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Rheumatology Physician. Quality dim: 88.6. Cost dim: 88.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Megan Bielawski, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 471 N CLEVELAND MASSILLON RD, Akron, OH, 44333, with a listed phone of (330) 668-4045. NPI 1073900080 was issued on 04/17/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Bielawski most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,494 prescription claims written by this provider, covering 492 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 14% brand-name and 86% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93/100 for the 2023 performance year (Quality 88.6, Cost 88), compared with the national average of 83.1.
Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1073900080 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/17/2015 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Megan Bielawski, M.D.'s current license status, disciplinary history, and board certifications with the State Medical Board of Ohio in Ohio before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Megan Bielawski, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Megan Bielawski, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.5K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Ohio OMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 - they are NOT specific to Megan Bielawski, M.D.. To verify Megan Bielawski, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
14% brand-name claims vs 86% generic, on 2,494 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,664
- Total Day Supply
- 137,538
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $94K
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.40
- Gender Split
- 74% female / 26% male
- Age Distribution
- <65: 33, 65-74: 246, 75-84: 180, 85+: 33
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Megan Bielawski, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
645 claims
- Methotrexate
Methotrexate
468 claims
- Prednisone 241
Prednisone
241 claims
- Leflunomide 214
Leflunomide
214 claims
- Sulfasalazine Dr 133
Sulfasalazine Dr
133 claims
- Alendronate Sodium 125
Alendronate Sodium
125 claims
- Allopurinol 65
Allopurinol
65 claims
- Meloxicam 62
Meloxicam
62 claims
| Drug | Claims |
|---|---|
| Hydroxychloroquine Sulfate | 645 |
| Methotrexate Methotrexate Sodium | 468 |
| Prednisone | 241 |
| Leflunomide | 214 |
| Sulfasalazine Dr Sulfasalazine | 133 |
| Alendronate Sodium | 125 |
| Allopurinol | 65 |
| Meloxicam | 62 |
| Leucovorin Calcium | 58 |
| Enbrel Sureclick Etanercept | 49 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Megan Bielawski, M.D. fits within the Rheumatology Physician landscape nationally.
Megan Bielawski, M.D.'s 2,494 claims are above the specialty average of 2,054.
Nearby Rheumatology Physician Providers in Ohio
Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as Bielawski.
Compare Rheumatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Ohio medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Ohio
Frequently Asked Questions
What is Megan Bielawski, M.D.'s specialty? ▼
How much does Megan Bielawski, M.D. prescribe under Medicare Part D? ▼
What is Megan Bielawski, M.D.'s Medicare quality score? ▼
Where is Megan Bielawski, M.D. located? ▼
What is Megan Bielawski, M.D.'s NPI number? ▼
Does Megan Bielawski, M.D. prescribe more brand-name or generic drugs? ▼
How many Rheumatology Physician providers are there in the US? ▼
What drugs does Megan Bielawski, M.D. prescribe most often? ▼
Does Megan Bielawski, M.D. accept Medicare? ▼
How can I verify Megan Bielawski, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology